Therefore, targeting lipid metabolism or boosting autophagy through the AMPK/mTOR pathway could serve as potential therapeutic strategies for managing obesity-related depression. This evidence concerns the gene PRKAB1 and obesity due to melanocortin 4 receptor deficiency.